Search

Search Constraints

You searched for: Author/Creator Milde, Till

Search Results

1. A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development. Issue 4 (12th July 2021)

2. A synergistic interaction between HDAC‐ and PARP inhibitors in childhood tumors with chromothripsis. Issue 4 (28th April 2022)

3. Accurate calling of KIAA1549‐BRAF fusions from DNA of human brain tumours using methylation array‐based copy number and gene panel sequencing data. (17th January 2021)

4. ATRT-05. Infants and newborns with atypical teratoid/rhabdoid tumors (ATRT) and extracranial malignant rhabdoid tumors: a unique and challenging population. (3rd June 2022)

5. BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma. Issue 4 (17th August 2022)

6. Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience. (June 2019)

7. Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma. Issue 4 (1st March 2018)

8. Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71–84]. (May 2023)

9. DDEL-01. The role of key pharmacodynamic and pharmacokinetic parameters in drug response prediction of pediatric tumors in the precision oncology study INFORM. (3rd June 2022)

10. EMBR-01. CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA. (1st June 2021)